Business Development

SelectX is actively seeking partnerships with leading pharmaceutical and biotechnology companies for the following:

• Advancement of the development of SXP2523, our aminoglycoside antibiotic program

• Non-antibiotic aminoglycosides (naAGs) and glycomimetics for other indications including inflammation, cancer, or metabolic diseases

If you are interested in discussing these or any other potential application of our Aminoglycoside Platform, please contact:

info@selectxpharm.com

SelectX Pharmaceuticals, Inc.
607 Boylston St, LL
Boston, MA  02116
Phone: (508) 798-0216